Zobrazeno 1 - 10
of 307
pro vyhledávání: '"R. K. Mirakhur"'
Autor:
R. K. Mirakhur, Rosemary M G Hogg
Publikováno v:
Expert Review of Neurotherapeutics. 9:599-608
Neostigmine, the currently used agent for reversal of neuromuscular block, has several drawbacks, such as a slow onset of peak effect, inability to reverse deep block and the occurrence of widespread muscarinic effects. Sugammadex is a new class of r
Autor:
R. K. Mirakhur
Publikováno v:
Anaesthesia. 40:254-258
Glycopyrronium 10 micrograms/kg has been compared with atropine 20 micrograms/kg in a mixture with neostigmine 50 micrograms/kg administered for antagonism of residual nondepolarising neuromuscular block in patients over 65 years of age. The initial
Publikováno v:
Anaesthesia. 40:263-269
In a randomised double-blind trial carried out on fit, unpremedicated patients undergoing standard minor operations with early postoperative mobility, using a standard form of anaesthesia, pretreatment with diazepam 0.15 mg/kg or midazolam 0.1 mg/kg
Publikováno v:
Anaesthesia. 48:940-945
Summary Mivacurium chloride has been assessed in respect of intubating conditions and neuromuscular effects. The influence of suxamethonium on the onset and duration of subsequently administered mivacurium was also studied. A dose of 0.15 mg.kg−1 o
Autor:
L. Aguilera, C. Gomar, M. E. Prins, Jm Hunter, C. Meistelman, Francesco Giunta, R. K. Mirakhur, Ea Flockton, P. Mastronardi
Background Reversal of the residual effect of rocuronium or cisatracurium by neostigmine may be slow and associated with side-effects. This randomized, safety-assessor-blinded study compared the efficacy of sugammadex, a selective relaxant binding ag
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::46c6475dcb5dc6f7a9ebf2e32e7af378
http://hdl.handle.net/11588/421767
http://hdl.handle.net/11588/421767
Publikováno v:
British Journal of Anaesthesia. 85:717-723
The excretion of rocuronium and its potential metabolites was studied in 38 anaesthetized patients, ASA I-III and 21-69 yr old. Rocuronium bromide was administered as an i.v. bolus dose of 0.3 or 0.9 mg kg-1. In Part A of the study, the excretion int
Publikováno v:
Anaesthesia. 55:859-863
The neuromuscular blocking effects of a single dose of rapacuronium 1.5 mg x kg(-1) with or without reversal with neostigmine have been examined in the present study and compared with a dose of succinylcholine 1.0 mg x kg(-1). Neuromuscular block was
Publikováno v:
Anaesthesia. 48:103-105
The neuromuscular effects of intravenous rocuronium bromide, 0.6 mg.kg-1 or 0.9 mg.kg-1, were studied in four groups of 10 patients during anaesthesia with or without halothane (0.5-0.75% inspired concentration). Neuromuscular block was monitored usi
A comparison of the neuromuscular blocking effects and reversibility of cisatracurium and atracurium
Publikováno v:
Anaesthesia. 53:744-748
The neuromuscular blocking effects and the reversibility of cisatracurium 0.1 or 0.15 mgkg−1 were compared with those of atracurium 0.5 mgkg−1 during anaesthesia with propofol, nitrous oxide and isoflurane. Neuromuscular block was monitored using
Publikováno v:
Anaesthesia. 53:231-237
Eighty women undergoing elective Caesarean section under spinal anaesthesia using hyperbaric bupivacaine 0.5% were randomly allocated to receive, in addition, intrathecal diamorphine 0.125, 0.25 or 0.375 mg or saline. Postoperative morphine requireme